These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25646622)

  • 21. IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection.
    Palatini M; Müller SF; Kirstgen M; Leiting S; Lehmann F; Soppa L; Goldmann N; Müller C; Lowjaga KAAT; Alber J; Ciarimboli G; Ziebuhr J; Glebe D; Geyer J
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.
    Yan H; Zhong G; Xu G; He W; Jing Z; Gao Z; Huang Y; Qi Y; Peng B; Wang H; Fu L; Song M; Chen P; Gao W; Ren B; Sun Y; Cai T; Feng X; Sui J; Li W
    Elife; 2012 Nov; 3():. PubMed ID: 25409679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection.
    Heuschkel MJ; Baumert TF; Verrier ER
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of Na
    Zakrzewicz D; Geyer J
    Biol Chem; 2023 Jun; 404(7):673-690. PubMed ID: 37103224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.
    Fu L; Hu H; Liu Y; Jing Z; Li W
    Virology; 2017 May; 505():1-11. PubMed ID: 28213271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes.
    Verrier ER; Colpitts CC; Bach C; Heydmann L; Zona L; Xiao F; Thumann C; Crouchet E; Gaudin R; Sureau C; Cosset FL; McKeating JA; Pessaux P; Hoshida Y; Schuster C; Zeisel MB; Baumert TF
    Cell Rep; 2016 Oct; 17(5):1357-1368. PubMed ID: 27783949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
    Takemori T; Sugimoto-Ishige A; Nishitsuji H; Futamura Y; Harada M; Kimura-Someya T; Matsumoto T; Honma T; Tanaka M; Yaguchi M; Isono K; Koseki H; Osada H; Miki D; Saito T; Tanaka T; Fukami T; Goto T; Shirouzu M; Shimotohno K; Chayama K
    J Virol; 2022 Mar; 96(5):e0168621. PubMed ID: 34985994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L; Sui J; Luo G
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice.
    Slijepcevic D; Kaufman C; Wichers CG; Gilglioni EH; Lempp FA; Duijst S; de Waart DR; Elferink RP; Mier W; Stieger B; Beuers U; Urban S; van de Graaf SF
    Hepatology; 2015 Jul; 62(1):207-19. PubMed ID: 25641256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual Agonist of Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo.
    Ito K; Okumura A; Takeuchi JS; Watashi K; Inoue R; Yamauchi T; Sakamoto K; Yamashita Y; Iguchi Y; Une M; Wakita T; Umezawa K; Yoneda M
    Hepatology; 2021 Jul; 74(1):83-98. PubMed ID: 33434356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
    Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
    J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening.
    Kirstgen M; Müller SF; Lowjaga KAAT; Goldmann N; Lehmann F; Alakurtti S; Yli-Kauhaluoma J; Baringhaus KH; Krieg R; Glebe D; Geyer J
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
    Ueda Y; Gu W; Dansako H; Nishitsuji H; Satoh S; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 2019 Jul; 515(1):156-162. PubMed ID: 31133379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP.
    Li H; Zhuang Q; Wang Y; Zhang T; Zhao J; Zhang Y; Zhang J; Lin Y; Yuan Q; Xia N; Han J
    Cell Mol Immunol; 2014 Mar; 11(2):175-83. PubMed ID: 24509445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies to inhibit entry of HBV and HDV into hepatocytes.
    Urban S; Bartenschlager R; Kubitz R; Zoulim F
    Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.
    Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S
    Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide.
    Toniutto P; Falleti E; Cmet S; Cussigh A; Degasperi E; Anolli MP; Sambarino D; Facchetti F; Borghi M; Perbellini R; Monico S; Lampertico P
    J Hepatol; 2024 Nov; 81(5):819-826. PubMed ID: 38901675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.
    Fukano K; Oshima M; Tsukuda S; Aizaki H; Ohki M; Park SY; Wakita T; Wakae K; Watashi K; Muramatsu M
    J Virol; 2021 Nov; 95(24):e0093821. PubMed ID: 34613794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
    Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T
    Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.
    Winer BY; Shirvani-Dastgerdi E; Bram Y; Sellau J; Low BE; Johnson H; Huang T; Hrebikova G; Heller B; Sharon Y; Giersch K; Gerges S; Seneca K; Pais MA; Frankel AS; Chiriboga L; Cullen J; Nahass RG; Lutgehetmann M; Toettcher JE; Wiles MV; Schwartz RE; Ploss A
    Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.